Skip to main navigation Skip to search Skip to main content

Clinical outcomes of WHO2022 and ICC MDS entities with risk stratification by IPSS-R and IPSS-M

  • The Catholic University of Korea, College of Medicine
  • Catholic Univ. of Korea Coll. Med.

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Conceptualization and design by YK, Y-JK and MK. Patient data and samples by DK, SYP, SP and Y-JK. Review pathologic and genetic analysis by JJ, HSK, J-ML, AA, YK and MK. Review clinical data by SP and Y-JK. Experiments, collections, and assembly of data by DK, BB, JJ, HSK, J-ML, AA, JSY and SYP. Data analysis and interpretation by DK, BB, YK, Y-JK and MK. Manuscript writing and editing by DK, BB, Y-JK and MK. All authors have read and agreed to the published version of the manuscript.

Original languageEnglish
Pages (from-to)1422-1423
Number of pages2
JournalHaematologica
Volume111
Issue number4
DOIs
StatePublished - 2026

Bibliographical note

Publisher Copyright:
© 2026 Ferrata Storti Foundation

Fingerprint

Dive into the research topics of 'Clinical outcomes of WHO2022 and ICC MDS entities with risk stratification by IPSS-R and IPSS-M'. Together they form a unique fingerprint.

Cite this